Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Market Closed - NYSE Other stock markets 00:00:02 12/06/2026 +04			5-day change	1st Jan Change
42.12 ^USD	-0.14%		+7.72%	+13.96%

06-10	IMAX Corporation - Shareholder/Analyst Call
06-01	Domestic Box Office Poised for Continued Momentum After May Beat, B. Riley Says	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

38d804f039fd0a87daf7957112675.3CpIc_FMssA08NqtTjSnpzhf0N1gp0n1HzqXXtAs9pA.kn8xFYAA_qZVr53yPwDr8ksVubkGlSebZXCmLZxes8GvH3sjmXnf9UO46g~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

05-18	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
05-04	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
05-01	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
04-23	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
04-17	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
02-27	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
02-26	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
02-26	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
12-15	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
12-08	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
12-08	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
12-08	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT
12-08	B. Riley Raises Price Target on IMAX to $44 From $40, Keeps Buy Rating	MT
11-25	Goldman Sachs Upgrades IMAX to Neutral From Sell, Adjusts Price Target to $34 From $22	MT
24/10/25	IMAX Reports 'Superb' Q3 Results, Wedbush Says	MT
20/10/25	US Box Office Set to Rebound in Fourth Quarter, B. Riley Says	MT
22/09/25	Imax Likely to Surpass 'Peak' EBITDA Margins in Two Years, Wedbush Says	MT
22/09/25	Wedbush Raises Price Target on IMAX to $39 From $35, Keeps Outperform Rating	MT
19/09/25	Barrington Raises Price Target on IMAX to $37 From $32, Keeps Outperform Rating	MT
28/07/25	Macquarie Raises Price Target on IMAX to $35 From $32, Keeps Outperform Rating	MT
25/07/25	IMAX's Q2 Results Beat Estimates With Box Office Outperformance, Market Share Gains, Wedbush Says	MT
25/07/25	Wedbush Lifts Price Target on IMAX to $35 From $34, Keeps Outperform Rating	MT
11/07/25	IMAX Poised for Higher Market Share, Margins From Growing Camera Film Slate, Wedbush Says	MT
11/07/25	Wedbush Lifts Price Target on IMAX to $34 From $32, Keeps Outperform Rating	MT
20/02/25	Imax Poised for Double-Digit Growth in 2025, Wedbush Says	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Objective/dr gap
IMAX CORPORATION		+11%
BOLLORÉ SE		+1.2%
TKO GROUP HOLDINGS, INC.		+13.54%
WARNER MUSIC GROUP CORP.		+32.86%
TOEI ANIMATION CO.,LTD.		+33.87%
SEGA SAMMY HOLDINGS INC.		+38.88%
VIVENDI SE		+24.53%
TOEI COMPANY, LTD.	-	+0.53%
HAVAS N.V.		+22.22%
Average		+19.85%
Weighted average by Cap.		+16.96%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

42.18USD

Average target price

46.82USD

Spread / Average Target

+11.00%

High Price Target

60.00USD

Spread / Highest target

+42.25%

Low Price Target

41.00USD

Spread / Lowest Target

-2.80%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barrington Research
Macquarie
B. Riley
JPMorgan Chase
Wedbush
Goldman Sachs
Buckingham Research
Rosenblatt Securities
Benchmark Company
Roth MKM
Wells Fargo Securities
Morningstar
Truist Securities
Benchmark Capital
MKM Partners
Colliers Securities